Stockreport

Neos Therapeutics Announces Issuance of New U.S. Methods of Use Patent for N-desethyloxybutynin

NEOS THERAPEUTICS  (NEOS) 
Last neos therapeutics earnings: 8/8 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: neostx.com
PDF DALLAS and FORT WORTH, Texas, April 09, 2020 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ: NEOS), a commercial-stage pharmaceutical company developing and manuf [Read more]